申请人:Roppe Jeffrey Roger
公开号:US20120214840A1
公开(公告)日:2012-08-23
Described herein are compounds and pharmaceutical compositions containing such compounds, which inhibit the activity of 5-lipoxygenase (5-LO). Also described herein are methods of using such 5-LO inhibitors, alone and in combination with other compounds, for treating respiratory, cardiovascular, and other leukotriene-dependent or leukotriene mediated conditions, diseases, or disorders.
本文所述的是含有这些化合物的药物组合物,这些化合物抑制5-脂氧化酶(5-LO)的活性。本文还描述了使用这种5-LO抑制剂的方法,单独或与其他化合物联合使用,用于治疗呼吸系统、心血管系统和其他依赖或介导白三烯的情况、疾病或障碍。